Validation of baicalein and oridonin as nonspecific SARS-CoV-2 main protease inhibitors

被引:2
|
作者
Yan, Haohao [1 ]
Zhang, Rui [1 ]
Yan, Gangan [1 ]
Liu, Xiaoping [1 ]
Li, Ni [2 ]
Chen, Yunyu [1 ]
机构
[1] Wannan Med Coll, Inst Drug Screening & Evaluat, Wuhu 241002, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1002/ptr.7829
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1161 / 1164
页数:4
相关论文
共 50 条
  • [1] Allosteric inhibitors of the main protease of SARS-CoV-2
    Samrat, Subodh Kumar
    Xu, Jimin
    Xie, Xuping
    Gianti, Eleonora
    Chen, Haiying
    Zou, Jing
    Pattis, Jason G.
    Elokely, Khaled
    Lee, Hyun
    Li, Zhong
    Klein, Michael L.
    Shi, Pei-Yong
    Zhou, Jia
    Li, Hongmin
    ANTIVIRAL RESEARCH, 2022, 205
  • [2] Developing inhibitors of the SARS-CoV-2 main protease
    Seitz, Christian
    Markota, Vedran
    Sztain-Pedone, Terra
    Esler, Morgan
    Moghadasi, Arad
    Kennelly, Samantha
    Demir, Ozlem
    Aihara, Hideki
    Harki, Daniel A.
    Harris, Reuben
    McCammon, J. Andrew
    Amaro, Rommie E.
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 192A - 192A
  • [3] Potential SARS-CoV-2 main protease inhibitors
    Banerjee, Riddhidev
    Perera, Lalith
    Tillekeratne, L. M. Viranga
    DRUG DISCOVERY TODAY, 2021, 26 (03) : 804 - 816
  • [4] On the origins of SARS-CoV-2 main protease inhibitors
    Janin, Yves L.
    RSC MEDICINAL CHEMISTRY, 2024, 15 (01): : 81 - 118
  • [5] Peptidomimetic inhibitors of SARS-COV-2 main protease
    Angeles Bonache, Ma.
    Algar, Sergio
    Medina, Jessy
    Diaz-Agustin, Aitor
    Bueno, Paula
    Castro, Victoria
    Fabrega, Montserrat
    Coll, Miquel
    Garaigorta, Urtzi
    Gastaminza, Pablo
    Martin Martinez, Mercedes
    Gonzalez-Muniz, Rosario
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30
  • [6] Perspectives on SARS-CoV-2 Main Protease Inhibitors
    Gao, Kaifu
    Wang, Rui
    Chen, Jiahui
    Tepe, Jetze J.
    Huang, Faqing
    Wei, Guo-Wei
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (23) : 16922 - 16955
  • [7] Discovery of novel inhibitors of SARS-CoV-2 main protease
    Zheng, Lei
    Chen, Yanmei
    Bao, Jingxiao
    He, Liping
    Dong, Suzhen
    Qi, Yifei
    Zhang, John Z. H.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (23): : 12526 - 12534
  • [8] Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
    Huff, Sarah
    Kummetha, Indrasena Reddy
    Tiwari, Shashi Kant
    Huante, Matthew B.
    Clark, Alex E.
    Wang, Shaobo
    Bray, William
    Smith, Davey
    Carlin, Aaron F.
    Endsley, Mark
    Rana, Tariq M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 2866 - 2879
  • [9] Potent and biostable inhibitors of the main protease of SARS-CoV-2
    Tsuji, Kohei
    Ishii, Takahiro
    Kobayakawa, Takuya
    Higashi-Kuwata, Nobuyo
    Azuma, Chika
    Nakayama, Miyuki
    Onishi, Takato
    Nakano, Hiroki
    Wada, Naoya
    Hori, Miki
    Shinohara, Kouki
    Miura, Yutaro
    Kawada, Takuma
    Hayashi, Hironori
    Hattori, Shin-ichiro
    Bulut, Haydar
    Das, Debananda
    Takamune, Nobutoki
    Kishimoto, Naoki
    Saruwatari, Junji
    Okamura, Tadashi
    Nakano, Kenta
    Misumi, Shogo
    Mitsuya, Hiroaki
    Tamamura, Hirokazu
    ISCIENCE, 2022, 25 (11)
  • [10] Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
    Katagishi, Daiki
    Yasuda, Daisuke
    Takahashi, Kyoko
    Nakamura, Shigeo
    Mashino, Tadahiko
    Ohe, Tomoyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 80